Logo image of ABCM

ABCAM PLC-SPON ADR (ABCM) Stock Fundamental Analysis

USA - NASDAQ:ABCM - US0003802040 - ADR

23.99 USD
+0.01 (+0.04%)
Last: 12/5/2023, 8:00:00 PM
23.99 USD
0 (0%)
After Hours: 12/5/2023, 8:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ABCM. ABCM was compared to 540 industry peers in the Biotechnology industry. ABCM has only an average score on both its financial health and profitability. ABCM is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

ABCM had positive earnings in the past year.
ABCM had a positive operating cash flow in the past year.
ABCM Yearly Net Income VS EBIT VS OCF VS FCFABCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.64%, ABCM belongs to the top of the industry, outperforming 93.86% of the companies in the same industry.
With an excellent Return On Equity value of 0.93%, ABCM belongs to the best of the industry, outperforming 93.86% of the companies in the same industry.
ABCM has a Return On Invested Capital of 1.98%. This is amongst the best in the industry. ABCM outperforms 94.69% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ABCM is significantly below the industry average of 15.95%.
The last Return On Invested Capital (1.98%) for ABCM is well below the 3 year average (6.00%), which needs to be investigated, but indicates that ABCM had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.64%
ROE 0.93%
ROIC 1.98%
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
ABCM Yearly ROA, ROE, ROICABCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 5 10 15

1.3 Margins

With an excellent Profit Margin value of 1.94%, ABCM belongs to the best of the industry, outperforming 94.86% of the companies in the same industry.
In the last couple of years the Profit Margin of ABCM has declined.
ABCM has a better Operating Margin (8.70%) than 95.36% of its industry peers.
ABCM's Operating Margin has declined in the last couple of years.
ABCM's Gross Margin of 72.69% is amongst the best of the industry. ABCM outperforms 83.58% of its industry peers.
ABCM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.7%
PM (TTM) 1.94%
GM 72.69%
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
ABCM Yearly Profit, Operating, Gross MarginsABCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

ABCM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ABCM has been increased compared to 1 year ago.
ABCM has a better debt/assets ratio than last year.
ABCM Yearly Shares OutstandingABCM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M
ABCM Yearly Total Debt VS Total AssetsABCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 8.64 indicates that ABCM is not in any danger for bankruptcy at the moment.
ABCM has a better Altman-Z score (8.64) than 85.41% of its industry peers.
ABCM has a debt to FCF ratio of 19.99. This is a negative value and a sign of low solvency as ABCM would need 19.99 years to pay back of all of its debts.
ABCM's Debt to FCF ratio of 19.99 is amongst the best of the industry. ABCM outperforms 94.03% of its industry peers.
ABCM has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
ABCM has a worse Debt to Equity ratio (0.30) than 71.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 19.99
Altman-Z 8.64
ROIC/WACC0.22
WACC8.89%
ABCM Yearly LT Debt VS Equity VS FCFABCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.26 indicates that ABCM should not have too much problems paying its short term obligations.
ABCM has a worse Current ratio (1.26) than 86.73% of its industry peers.
A Quick Ratio of 0.98 indicates that ABCM may have some problems paying its short term obligations.
ABCM's Quick ratio of 0.98 is on the low side compared to the rest of the industry. ABCM is outperformed by 88.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.98
ABCM Yearly Current Assets VS Current LiabilitesABCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 402.64% over the past year.
The earnings per share for ABCM have been decreasing by -17.30% on average. This is quite bad
Looking at the last year, ABCM shows a quite strong growth in Revenue. The Revenue has grown by 17.70% in the last year.
Measured over the past years, ABCM shows a quite strong growth in Revenue. The Revenue has been growing by 11.64% on average per year.
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%

3.2 Future

ABCM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.12% yearly.
Based on estimates for the next years, ABCM will show a quite strong growth in Revenue. The Revenue will grow by 11.28% on average per year.
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ABCM Yearly Revenue VS EstimatesABCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
ABCM Yearly EPS VS EstimatesABCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 44.43, ABCM can be considered very expensive at the moment.
Based on the Price/Earnings ratio, ABCM is valued cheaply inside the industry as 94.69% of the companies are valued more expensively.
ABCM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.20.
With a Price/Forward Earnings ratio of 49.32, ABCM can be considered very expensive at the moment.
94.53% of the companies in the same industry are more expensive than ABCM, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, ABCM is valued quite expensively.
Industry RankSector Rank
PE 44.43
Fwd PE 49.32
ABCM Price Earnings VS Forward Price EarningsABCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ABCM indicates a rather cheap valuation: ABCM is cheaper than 94.20% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABCM indicates a rather cheap valuation: ABCM is cheaper than 93.86% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 374.67
EV/EBITDA 55.61
ABCM Per share dataABCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

ABCM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ABCM may justify a higher PE ratio.
ABCM's earnings are expected to grow with 52.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y68.04%
EPS Next 3Y52.49%

More info and screens

0

5. Dividend

5.1 Amount

ABCM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ABCAM PLC-SPON ADR

NASDAQ:ABCM (12/5/2023, 8:00:00 PM)

After market: 23.99 0 (0%)

23.99

+0.01 (+0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)09-12 2022-09-12/dmh
Earnings (Next)N/A N/A
Inst Owners1.79%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.49B
Analysts80
Price Target20.23 (-15.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 44.43
Fwd PE 49.32
P/S 12.3
P/FCF 374.67
P/OCF 79.64
P/B 5.92
P/tB 42.37
EV/EBITDA 55.61
EPS(TTM)0.54
EY2.25%
EPS(NY)0.49
Fwd EY2.03%
FCF(TTM)0.06
FCFY0.27%
OCF(TTM)0.3
OCFY1.26%
SpS1.95
BVpS4.05
TBVpS0.57
PEG (NY)0.35
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.64%
ROE 0.93%
ROCE 3.54%
ROIC 1.98%
ROICexc 2.23%
ROICexgc 7.95%
OM 8.7%
PM (TTM) 1.94%
GM 72.69%
FCFM 3.28%
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
ROICexc(3y)7.76%
ROICexc(5y)11.54%
ROICexgc(3y)24.8%
ROICexgc(5y)47.7%
ROCE(3y)9.88%
ROCE(5y)14%
ROICexcg growth 3Y-57.08%
ROICexcg growth 5Y-37.19%
ROICexc growth 3Y-42.21%
ROICexc growth 5Y-23.94%
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 19.99
Debt/EBITDA 2.79
Cap/Depr 90.64%
Cap/Sales 12.16%
Interest Coverage 9.53
Cash Conversion 69.81%
Profit Quality 169.12%
Current Ratio 1.26
Quick Ratio 0.98
Altman-Z 8.64
F-Score5
WACC8.89%
ROIC/WACC0.22
Cap/Depr(3y)181.11%
Cap/Depr(5y)191.67%
Cap/Sales(3y)16.16%
Cap/Sales(5y)14.67%
Profit Quality(3y)125.12%
Profit Quality(5y)105.69%
High Growth Momentum
Growth
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
EBIT growth 1Y-18.45%
EBIT growth 3Y-22.8%
EBIT growth 5Y-5.74%
EBIT Next Year197.84%
EBIT Next 3Y63.16%
EBIT Next 5Y39.34%
FCF growth 1Y-42.5%
FCF growth 3Y-17.2%
FCF growth 5Y-14.26%
OCF growth 1Y66.98%
OCF growth 3Y4.34%
OCF growth 5Y8.73%